Cargando…

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist

Hepatocyte growth factor/scatter factor (HGF/SF) and its cognate receptor MET play several essential roles in embryogenesis and regeneration in postnatal life of epithelial organs such as the liver, kidney, lung, and pancreas, prompting a strong interest in harnessing HGF/SF-MET signalling for regen...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Nola, Giovanni, Leclercq, Bérénice, Mougel, Alexandra, Taront, Solenne, Simonneau, Claire, Forneris, Federico, Adriaenssens, Eric, Drobecq, Hervé, Iamele, Luisa, Dubuquoy, Laurent, Melnyk, Oleg, Gherardi, Ermanno, de Jonge, Hugo, Vicogne, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348577/ https://www.ncbi.nlm.nih.gov/pubmed/35905995 http://dx.doi.org/10.26508/lsa.202201424

Ejemplares similares

Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist
por: Simonneau, Claire, et al.
Publicado: (2015)

Thiocarbamate-Linked Polysulfonate–Peptide Conjugates As Selective Hepatocyte Growth Factor Receptor Binders
por: Besret, Soizic, et al.
Publicado: (2014)

A cysteine selenosulfide redox switch for protein chemical synthesis
por: Diemer, Vincent, et al.
Publicado: (2020)

Correction: A simple and traceless solid phase method simplifies the assembly of large peptides and the access to challenging proteins
por: Ollivier, N., et al.
Publicado: (2017)

A simple and traceless solid phase method simplifies the assembly of large peptides and the access to challenging proteins
por: Ollivier, N., et al.
Publicado: (2017)

Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding
por: Sigurdardottir, A. G., et al.
Publicado: (2015)

A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation
por: Vallarola, Antonio, et al.
Publicado: (2020)

Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET
por: Greenall, Sameer A., et al.
Publicado: (2012)

Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors
por: Mekki, Meriem Sarah, et al.
Publicado: (2018)

Miguel Llinás and the Structure of the Kringle Fold
por: Patthy, Laszlo
Publicado: (2021)

Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1)
por: Guarino, Salvatore R., et al.
Publicado: (2022)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging
por: Duranti, Claudia, et al.
Publicado: (2018)

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Publicado: (1995)

Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression
por: Mougel, Alexandra, et al.
Publicado: (2022)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

Role of the kringle‐like domain in glycoprotein NMB for its tumorigenic potential
por: Xie, Rudy, et al.
Publicado: (2019)

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
por: Parikh, Rahul A, et al.
Publicado: (2014)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”
por: Ricci, Giulia
Publicado: (2015)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
por: Rothenberger, Natalie J., et al.
Publicado: (2017)

Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System
por: Leem, Eunju, et al.
Publicado: (2016)

Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish
por: Grzegorski, Steven J., et al.
Publicado: (2020)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

An extended transcription factor regulatory network controls hepatocyte identity
por: Dubois‐Chevalier, Julie, et al.
Publicado: (2023)

Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain
Publicado: (1994)

A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met
por: Basilico, Cristina, et al.
Publicado: (2008)

Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?
por: Wang, Xiangdong, et al.
Publicado: (2010)

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression
por: NOGUCHI, EIICHIRO, et al.
Publicado: (2015)

Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma
por: Johnson, Jennifer, et al.
Publicado: (2015)

Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
por: García-Vilas, Javier A, et al.
Publicado: (2018)

Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity
por: Mogues, Tirsit, et al.
Publicado: (2004)

Potential Role of Kringle-Integrin Interaction in Plasmin and uPA Actions (A Hypothesis)
por: Takada, Yoshikazu
Publicado: (2012)

Voltage-Dependent Anion Channel-1, a Possible Ligand of Plasminogen Kringle 5
por: Liang, Yin-ku, et al.
Publicado: (2016)

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients
por: Felix, A S, et al.
Publicado: (2012)

Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells
por: Tate, Amanda, et al.
Publicado: (2006)

A Hepatocyte Growth Factor Receptor (Met)–Insulin Receptor hybrid governs hepatic glucose metabolism
por: Fafalios, Arlee, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d4s9pr07bl8j7e5nq3prt61n0b